Pharma news
Careers
The exodus of patent trial litigators was ‘an easy choice’ due to their new employer’s ‘scale, vision and entrepreneurial culture’. 18 September 2025
Americas
A notable Ninth Circuit ruling raises questions about disclosure that trade secrets plaintiffs will want to consider—particularly with regards to timing, says Carolyn Hoecker Luedtke of Munger, Tolles & Olson. 17 September 2025
Asia
From drug discovery to post-market surveillance, AI is rewriting the rules in pharma—and the patent system is struggling to keep up. At AIPPI’s World Congress 2025, Marisa Woutersen hears experts debate AI disclosure, inventive step, and inventorship. 16 September 2025
Americas
In the second of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax delve into the real reasons why medicine costs more in the US. 12 September 2025
Americas
Deal resolves just one case in Regeneron’s roll-call of actions against competitors looking to launch versions of a $6bn-a-year blockbuster eye-disease treatment. 11 September 2025
Americas
In the first of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax explore how legislative, judicial, and executive policies have dramatically altered the risks for drug innovation. 10 September 2025
Americas
Federal oversight, funding cuts, and patent uncertainties are forcing universities, startups, and pharma companies to reassess partnership models, finds Marisa Woutersen. 9 September 2025
Americas
The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech. 5 September 2025
Europe
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen. 4 September 2025
Biotech
Erik Viik of Papula-Nevinpat looks at the dynamics that international applicants need to be aware of to secure and manage their patent rights across the region. 2 September 2025